Published in Int J Inflam on July 18, 2011
Endothelial-derived oxidative stress drives myofibroblastic activation and calcification of the aortic valve. PLoS One (2015) 1.42
Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease. J Cell Sci (2015) 0.88
TGF-β mediates early angiogenesis and latent fibrosis in an Emilin1-deficient mouse model of aortic valve disease. Dis Model Mech (2014) 0.83
Development and characterization of acellular porcine pulmonary valve scaffolds for tissue engineering. Tissue Eng Part A (2014) 0.75
Cutaneous wound healing. N Engl J Med (1999) 19.12
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (1991) 11.44
A series of normal stages in the development of the chick embryo. 1951. Dev Dyn (1992) 11.04
The transforming growth factor-beta family. Annu Rev Cell Biol (1990) 10.62
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science (2006) 10.25
Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 10.17
Infective endocarditis in adults. N Engl J Med (2001) 9.95
Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80
Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol (1997) 7.45
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med (2008) 7.31
Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med (2007) 6.23
Bone formation and inflammation in cardiac valves. Circulation (2001) 6.01
Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci (2004) 5.59
Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet (1993) 5.09
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest (2004) 4.85
Infective endocarditis. Lancet (2004) 4.64
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation (1994) 4.32
Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation (2005) 4.19
The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14
Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem (2002) 3.92
Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol (1998) 3.68
Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci (1995) 3.68
Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol (2011) 3.65
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A (1991) 3.60
Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation (2001) 3.47
Drugs and valvular heart disease. N Engl J Med (2007) 3.41
Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development (1995) 3.19
The changing face of infective endocarditis. Heart (2005) 3.15
Asymmetric redirection of flow through the heart. Nature (2000) 2.99
Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res (2006) 2.91
Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation (2006) 2.68
Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol (2001) 2.57
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet (1997) 2.56
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res (2004) 2.45
Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg (2003) 2.38
Isolation and characterization of the cell-associated region of group A streptococcal M6 protein. J Bacteriol (1988) 2.35
Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol (1997) 2.28
Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol (2004) 2.28
The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material. Br Heart J (1978) 2.28
Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. J Biol Chem (1984) 2.25
The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol (2007) 2.18
An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res (2006) 2.14
Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun (2000) 2.11
Heart valve tissue engineering. Circ Res (2005) 2.08
Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation (2009) 2.07
Structural development of endocardial cushions. Am J Anat (1977) 2.07
Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci (1994) 2.07
Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis (2004) 2.02
Streptococcal M protein. Sci Am (1991) 1.98
From stem cells to viable autologous semilunar heart valve. Circulation (2005) 1.94
Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect Immun (1994) 1.92
Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol (2009) 1.89
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol (2009) 1.85
Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol (2006) 1.83
Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev (1990) 1.83
Heart valve structure and function in development and disease. Annu Rev Physiol (2011) 1.80
Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res (2005) 1.80
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
The cardiac valve interstitial cell. Int J Biochem Cell Biol (2003) 1.76
Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation (2006) 1.75
Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol (2005) 1.73
Mechanisms of aortic valve calcification. Am J Cardiol (2004) 1.72
Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol (2001) 1.72
Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg (2003) 1.71
Are atherosclerotic processes involved in aortic-valve calcification? Lancet (2000) 1.69
Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis. Heart (2007) 1.67
Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation (2002) 1.61
Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway. Arterioscler Thromb Vasc Biol (2008) 1.60
Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis. Am J Physiol Cell Physiol (2007) 1.58
Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol (1995) 1.58
Migratory behavior of cardiac cushion tissue cells in a collagen-lattice culture system. Dev Biol (1982) 1.49
Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis (2003) 1.49
Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res (2006) 1.47
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol (2003) 1.47
Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol (1994) 1.46
Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res (2006) 1.46
Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med (2002) 1.46
Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest (2000) 1.46
Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res (1994) 1.42
Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: influence of shear stress. Arterioscler Thromb Vasc Biol (2005) 1.41
Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol (2007) 1.41
Role of TGF beta-mediated inflammation in cutaneous wound healing. J Investig Dermatol Symp Proc (2006) 1.39
Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol (2000) 1.38
Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng (2006) 1.36
Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg (2007) 1.36
Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol (2005) 1.35
Cell biology of valvular interstitial cells. Can J Cardiol (1996) 1.33
Long-term serotonin administration induces heart valve disease in rats. Circulation (2005) 1.32
Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India. Bull World Health Organ (1993) 1.31
Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis (2000) 1.31
Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol (2002) 1.30
Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner. Am J Pathol (2010) 1.29
Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor beta3. Dev Dyn (1997) 1.29
Osteogenesis imperfecta and cardiovascular diseases. Ann Thorac Surg (1995) 1.27
Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Ann N Y Acad Sci (2008) 1.43
3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J Biomed Mater Res A (2012) 1.41
An ex-ovo chicken embryo culture system suitable for imaging and microsurgery applications. J Vis Exp (2010) 1.20
Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells. Arterioscler Thromb Vasc Biol (2012) 1.09
Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am J Pathol (2013) 1.07
Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels. Acta Biomater (2013) 1.02
Hemodynamic patterning of the avian atrioventricular valve. Dev Dyn (2011) 1.02
Quantitative in vivo imaging of embryonic development: opportunities and challenges. Differentiation (2012) 0.99
Cyclic strain anisotropy regulates valvular interstitial cell phenotype and tissue remodeling in three-dimensional culture. Acta Biomater (2012) 0.97
Isolation of valvular endothelial cells. J Vis Exp (2010) 0.96
Quantitative three-dimensional imaging of live avian embryonic morphogenesis via micro-computed tomography. Dev Dyn (2011) 0.95
Quantitative three-dimensional analysis of embryonic chick morphogenesis via microcomputed tomography. Anat Rec (Hoboken) (2011) 0.94
Two-photon microscopy-guided femtosecond-laser photoablation of avian cardiogenesis: noninvasive creation of localized heart defects. Am J Physiol Heart Circ Physiol (2010) 0.93
Cyclic strain regulates pro-inflammatory protein expression in porcine aortic valve endothelial cells. J Heart Valve Dis (2008) 0.91
Transforming growth factor β, bone morphogenetic protein, and vascular endothelial growth factor mediate phenotype maturation and tissue remodeling by embryonic valve progenitor cells: relevance for heart valve tissue engineering. Tissue Eng Part A (2010) 0.87
Serotonin potentiates transforming growth factor-beta3 induced biomechanical remodeling in avian embryonic atrioventricular valves. PLoS One (2012) 0.85
Heterogeneous susceptibility of valve endothelial cells to mesenchymal transformation in response to TNFα. Ann Biomed Eng (2013) 0.84
Translational paradigms in scientific and clinical imaging of cardiac development. Birth Defects Res C Embryo Today (2013) 0.84
Computational simulation of hemodynamic-driven growth and remodeling of embryonic atrioventricular valves. Biomech Model Mechanobiol (2012) 0.83
Effects of shear stress pattern and magnitude on mesenchymal transformation and invasion of aortic valve endothelial cells. Biotechnol Bioeng (2014) 0.83
The mechanobiology of mitral valve function, degeneration, and repair. J Vet Cardiol (2012) 0.82
Cadherin-11 expression patterns in heart valves associate with key functions during embryonic cushion formation, valve maturation and calcification. Cells Tissues Organs (2013) 0.81
Quantification of embryonic atrioventricular valve biomechanics during morphogenesis. J Biomech (2011) 0.80
The next frontier in cardiovascular developmental biology--an integrated approach to adult disease? Nat Clin Pract Cardiovasc Med (2007) 0.80
Computational fluid dynamics of developing avian outflow tract heart valves. Ann Biomed Eng (2012) 0.80
Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions. Expert Opin Biol Ther (2015) 0.79
Interactions between TGFβ1 and cyclic strain in modulation of myofibroblastic differentiation of canine mitral valve interstitial cells in 3D culture. J Vet Cardiol (2012) 0.79
Characterization of multiple myeloma clonal cell expansion and stromal Wnt/β-catenin signaling in hyaluronic acid-based 3D hydrogel. In Vivo (2014) 0.78
Cardiac developmental toxicity. Birth Defects Res C Embryo Today (2011) 0.78
Micro/nano-computed tomography technology for quantitative dynamic, multi-scale imaging of morphogenesis. Methods Mol Biol (2015) 0.77
Valvular heart diseases in the developing world: developmental biology takes center stage. J Heart Valve Dis (2012) 0.76
Hierarchical approaches for systems modeling in cardiac development. Wiley Interdiscip Rev Syst Biol Med (2013) 0.75
Growth and hemodynamics after early embryonic aortic arch occlusion. Biomech Model Mechanobiol (2014) 0.75
Method for non-optical quantification of in situ local soft tissue biomechanics. J Biomech (2013) 0.75